DLC1 抗体 (N-Term)
-
- 抗原 See all DLC1 抗体
- DLC1 (Deleted in Liver Cancer 1 (DLC1))
-
抗原表位
- N-Term
-
适用
- 人, 小鼠
-
宿主
- 山羊
-
克隆类型
- 多克隆
-
标记
- This DLC1 antibody is un-conjugated
-
应用范围
- Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- 原理
- DLC1 (Isoforms 1 and 3)
- 序列
- SVAIRKRSWE EHC
- 特异性
- This antibody is expected to recognise isoforms 1 and 3 ( NP_872584.2 and NP_079043.3 resp) but NOT isoform 2 (NP_006085.2).
- 交叉反应
- 人, 小鼠, Pig
- 纯化方法
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- 质量等级
- Verified
- 免疫原
- Peptide with sequence SVAIRKRSWEEHC, from the N Terminus of the protein sequence according to NP_872584.2, NP_079043.3.
- 亚型
- IgG
-
-
- 应用备注
-
Immunohistochemistry: Paraffin embedded Mouse Adrenal Gland. Recommended concentration: 4 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:64000.
- 说明
-
Immunofluorescence: Expression of the protein seen in the cytoplasm and nucleus of U251 and U2OS cells. Recommended concentration: 10μg/ml.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5 mg/mL
- 缓冲液
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Minimize freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 30, Issue 1, pp. 139-48, (2009) (PubMed).
: "
-
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 30, Issue 1, pp. 139-48, (2009) (PubMed).
-
- 抗原
- DLC1 (Deleted in Liver Cancer 1 (DLC1))
- 别名
- DLC1 (DLC1 产品)
- 别名
- ARHGAP7 antibody, HP antibody, STARD12 antibody, p122-RhoGAP antibody, rhogap7 antibody, DLC-1 antibody, StARD12 antibody, Dlc-1 antibody, A730069N07Rik antibody, Arhgap7 antibody, dlc-1 antibody, RhoGAP antibody, Dlc1 antibody, DLC1 Rho GTPase activating protein antibody, DLC1 Rho GTPase activating protein S homeolog antibody, rho GTPase-activating protein 7 antibody, deleted in liver cancer 1 antibody, DLC1 antibody, dlc1.S antibody, dlc1 antibody, LOC100456847 antibody, Dlc1 antibody, LOC100729904 antibody
- 背景
- DLC1, HP, ARHGAP7, STARD12, FLJ21120, p122-RhoGAP, deleted in liver cancer 1, Rho-GTPase-activating protein 7, START domain containing protein 12, StAR-related lipid, transfer protein 12, StAR-related lipid transfer (START) domain containing 12, deleted
- 基因ID
- 10395, 50768
- NCBI登录号
- NP_872584, NP_079043
- 途径
- Tube Formation, Positive Regulation of Endopeptidase Activity
-